Dietary supplement tested as potential new option for inflammatory bowel disease
NCT ID NCT04114292
Summary
This early-stage study tested whether TUDCA, a dietary supplement, could help control ulcerative colitis symptoms. Fourteen adults with active ulcerative colitis took TUDCA for six weeks while researchers monitored safety and measured changes in gut inflammation. The goal was to see if this supplement could become a new treatment option with fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
-
Barnes-Jewish West County Hospital
Creve Coeur, Missouri, 63141, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.